CUE
CUE
US22978P2056
Cue Biopharma, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 27.466.000 9.287.000
195.7%
Cost of Revenue -- --
--
Gross Profit -- --
--
53.987.000 50.880.000
6.1%
Operating Income -26.521.000 -41.593.000
36.2%
Pretax Income -26.102.000 -40.674.000
35.8%
Net Income Common Stockholders -26.602.000 -40.674.000
34.6%
-- --
--
-- --
--
ende